Inventor · disambiguated record
Dave A. Miller
Also filed as: MILLER DAVE · MILLER DAVE A · MILLER DAVE ALAN
11 granted patents·15 pending applications·54 citations·filing 2005–2025
89Inventor score
Top patents by PatentIndex Score
26 records- 0194US8486423B2Thermo-kinetic mixing for pharmaceutical applicationsBROUGH CHRIS·Filed 2008·Granted Jul 16, 2013·21 cites·52 claims
- 0289US10668085B2Thermo-kinetic mixing for pharmaceutical applicationsUNIV TEXAS·Filed 2018·Granted Jun 2, 2020·2 cites·21 claims
- 0388US9339440B2Thermo-kinetic mixing for pharmaceutical applicationsUNIV TEXAS·Filed 2013·Granted May 17, 2016·11 cites·32 claims
- 0486US10258608B2Formulations of deferasirox and methods of making the sameDISPERSOL TECHNOLOGIES LLC·Filed 2017·Granted Apr 16, 2019·3 cites·7 claims
- 0584US10022385B2Thermo-kinetic mixing for pharmaceutical applicationsUNIV TEXAS·Filed 2016·Granted Jul 17, 2018·3 cites·16 claims
- 0683US10265301B2Formulations of deferasirox and methods of making the sameDISPERSOL TECHNOLOGIES LLC·Filed 2016·Granted Apr 23, 2019·5 cites·24 claims
- 0782US12023343B2Thermo-kinetic mixing for pharmaceutical applicationsUNIV TEXAS·Filed 2022·Granted Jul 2, 2024·0 cites·19 claims
- 0881US9504658B2Stabilized HME composition with small drug particlesMILLER DAVE A·Filed 2005·Granted Nov 29, 2016·8 cites·20 claims
- 0973US9730894B2Stabilized HME composition with small drug particlesUNIV TEXAS·Filed 2016·Granted Aug 15, 2017·1 cites·28 claims
- 1073US2024091201A1Formulations of deferasirox and methods of making the sameAUSTINPX LLC·Filed 2023·Application pending·0 cites
- 1171US11439650B2Thermo-kinetic mixing for pharmaceutical applicationsUNIV TEXAS·Filed 2020·Granted Sep 13, 2022·0 cites·10 claims
- 1264US11878005B2Formulations of deferasirox and methods of making the sameAUSTINPX LLC·Filed 2019·Granted Jan 23, 2024·0 cites·23 claims
- 1362US2025360085A1Improved drug formulationsAUSTINPX LLC·Filed 2025·Application pending·0 cites
- 1455US2019142756A1Drug formulationsDISPERSOL TECHNOLOGIES LLC·Filed 2018·Application pending·0 cites
- 1551US2021128536A1Weakly basic drug and ionic polymer pharmaceutical formulations and methods of formation and administration thereofDISPERSOL TECHNOLOGIES LLC·Filed 2020·Application pending·0 cites
- 1648US2019091339A1Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereofDISPERSOL TECHNOLOGIES LLC·Filed 2018·Application pending·0 cites
- 1747US2021087191A1SUBSTITUTED 3-ISOBUTYL-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-a]ISOQUINOLIN-2-OL COMPOUNDS, THEIR SYNTHESIS, AND USE THEREOFDISPERSOL TECHNOLOGIES LLC·Filed 2020·Application pending·0 cites
- 1846US2022401579A1Inclusion complexes of pharmaceuticals and cyclic oligomersDISPERSOL TECHNOLOGIES LLC·Filed 2020·Application pending·0 cites
- 1945US2013331314A1Pharmaceutical composition for treating hcv infectionsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2044US2022362264A1Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereofDISPERSOL TECHNOLOGIES LLC·Filed 2020·Application pending·0 cites
- 2144US2014039031A1Pharmaceutical formulations of acetyl-11-keto-b-boswellic acid, diindolylmethane, and curcumin for pharmaceutical applicationsBROUGH CHRIS·Filed 2012·Application pending·0 cites
- 2240US2020009060A1Improved drug formulationsDISPERSOL TECHNOLOGIES LLC·Filed 2017·Application pending·0 cites
- 2340US2018280302A1Solid dispersions of compounds using polyvinyl alcohol as a carrier polymerMERCK PATENT GMBH·Filed 2015·Application pending·0 cites
- 2439US2012114751A1Pharmaceutical composition for treating hcv infectionsLEIMINER ANDREAS·Filed 2011·Application pending·0 cites
- 2537US2017333404A1Improved formulations of vemurafenib and methods of making the sameDISPERSOL TECHNOLOGIES LLC·Filed 2015·Application pending·0 cites
- 2633US2012213827A1Process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusionCHATTERJI ASHISH·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →